Richard Kadri-Langford
Monitoring Myopia Progression: Why Axial Length Measurements Are Taking the Lead
A recent article published in The Review of Myopia Management by Thomas Naduvilath, Msc Biostatistics, PhD, the Head of Biostatistics at...
top of page
Search
Dan Daly
- Dec 19, 2022
- 2 min
Occuity enters Boehringer Ingelheim start-ups acceleration program Synapse Acceleration®
Occuity enters Boehringer Ingelheim start-ups program Synapse Acceleration®, looking at non-invasive glucose monitoring in veterinary
170 views0 comments
Henry Tsang
- Nov 21, 2022
- 2 min
CooperVision Sign Letter of Intent for AX1 Global Distribution
Occuity is delighted to have received a letter of intent from world-leading contact lens manufacturer CooperVision, Inc, expressing their...
339 views0 comments
Richard Kadri-Langford
- Oct 21, 2022
- 1 min
Tech Start-up of the Year...
The Occuity Team was delighted to win "Tech Start-up of the Year" at The Business Magazine's prestigious Thames Valley Tech Awards 2022...
224 views0 comments
Kim Rasmussen
- Nov 1, 2021
- 3 min
Occuity becomes the largest MedTech raise ever on crowdfunding platform Seedrs, with £2.85m raise.
Occuity have successfully raised over £2.85m from more than 850 investors from over 38 countries, on the leading crowdfunding platform,...
187 views0 comments
Richard Kadri-Langford
- Oct 4, 2021
- 1 min
Crowdfunding Closes 10 pm Tonight
Please note our Seedrs crowdfunding round has now closed. However, if you are still interested in investing please contact us here Hello...
111 views0 comments
kimrasmussen5
- Sep 27, 2021
- 2 min
Longevitytech.fund make significant investment in Occuity
Whilst our crowdfunding campaign on Seedrs continues to overfund, we are also in discussion with several angel investors and investment...
142 views0 comments
Richard Kadri-Langford
- Sep 8, 2021
- 1 min
An Interview with Optometry Today
The launch of our crowdfunding round has generated a great deal of interest. We featured in a number of business publications, which have...
60 views0 comments
Richard Kadri-Langford
- Sep 8, 2021
- 1 min
Gavin Sandison is a diabetic AND investor in Occuity...
No energy, depressed, bedridden... ….But otherwise ‘fit & healthy’ and only 25 years of age! Gavin Sandison's childhood and adolescence...
49 views0 comments
Monica Giudice
- Aug 25, 2021
- 2 min
We are now Overfunding!
Just a day after our public launch on Seedrs, we’re delighted to announce that we have already hit our funding target. It’s a great...
59 views0 comments
Monica Giudice
- Aug 24, 2021
- 2 min
Occuity launches £1.8m crowdfunding round to deliver ophthalmic and optical diabetes devices
Today we launched a crowdfunding round to accelerate the development of new optical screening and monitoring devices that aim to detect...
80 views0 comments
Richard Kadri-Langford
- Nov 23, 2020
- 4 min
#BehindTheRaise - an interview with Occuity Founder & CEO, Dr Dan Daly
Following on from Occuity's successful investment round, our founder and CEO Dr. Dan Daly, spoke to the Angel Investment Network about...
154 views0 comments
Dan
- Oct 23, 2020
- 2 min
Angels invest in healthcare tech startup Occuity
Occuity are delighted to announce the successful raise of more than £1m. The raise will enable us to continue the development of novel...
238 views2 comments
Dan
- Oct 6, 2020
- 1 min
Occuity Unveil Inductive charging cradle for new non-contacting Optical Handheld Pachymeter
Occuity unveil the latest designs for the desktop charging cradle and calibration artefact for the new Optical Non-Contacting Pachymeter...
157 views0 comments
Dan
- Jun 5, 2020
- 1 min
Occuity show prototype optical handheld pachymeter taking corneal measurement from model eye
Occuity have released a video showing the fully handheld optical pachymeter prototype taking the corneal measurement from a model eye. ...
260 views0 comments
Dan
- Apr 16, 2020
- 1 min
Occuity gains EIS approval for UK Investment
On the 9th April 2020 Occuity received confirmation that the initial rounds of investment in Occuity were approved by HMRC under the...
144 views0 comments
bottom of page